Maureen Roden

4.8k total citations · 1 hit paper
13 papers, 3.3k citations indexed

About

Maureen Roden is a scholar working on Infectious Diseases, Epidemiology and Small Animals. According to data from OpenAlex, Maureen Roden has authored 13 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 9 papers in Epidemiology and 5 papers in Small Animals. Recurrent topics in Maureen Roden's work include Antifungal resistance and susceptibility (11 papers), Fungal Infections and Studies (7 papers) and Infectious Diseases and Mycology (4 papers). Maureen Roden is often cited by papers focused on Antifungal resistance and susceptibility (11 papers), Fungal Infections and Studies (7 papers) and Infectious Diseases and Mycology (4 papers). Maureen Roden collaborates with scholars based in United States, Malaysia and Germany. Maureen Roden's co-authors include Thomas J. Walsh, Robert L. Schaufele, Christine C. Chiou, Trine Alma Knudsen, Wendy Buchanan, Dimitrios P. Kontoyiannis, Michael Sein, Theoklis E. Zaoutis, Tin Sein and Junhao Chu and has published in prestigious journals such as Neurology, Clinical Infectious Diseases and Journal of Clinical Microbiology.

In The Last Decade

Maureen Roden

13 papers receiving 3.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases

2005 2.1k citations Maureen Roden, Theoklis E. Zaoutis et al. Clinical Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maureen Roden United States	9	3.0k	2.4k	444	377	261	13	3.3k
Robert L. Schaufele United States	20	3.5k 1.2×	2.8k 1.2×	562 1.3×	409 1.1×	263 1.0×	26	3.8k
Anna Skiada Greece	24	3.5k 1.2×	2.7k 1.1×	361 0.8×	493 1.3×	367 1.4×	36	4.1k
Wendy Buchanan United States	5	2.6k 0.9×	2.1k 0.9×	443 1.0×	234 0.6×	273 1.0×	5	2.9k
Ronald G. Washburn United States	20	1.6k 0.5×	1.1k 0.5×	223 0.5×	266 0.7×	120 0.5×	41	2.3k
Н Н Климко Russia	18	1.8k 0.6×	1.4k 0.6×	191 0.4×	192 0.5×	119 0.5×	94	2.0k
D. P. Kontoyiannis United States	17	1.7k 0.6×	1.4k 0.6×	304 0.7×	203 0.5×	51 0.2×	29	1.9k
G. Just‐Nübling Germany	19	1.6k 0.5×	1.4k 0.6×	265 0.6×	90 0.2×	44 0.2×	41	1.9k
John W. Hiemenz United States	14	1.4k 0.5×	1.3k 0.5×	293 0.7×	143 0.4×	32 0.1×	28	2.0k
Stephen Dummer United States	19	1.7k 0.6×	1.8k 0.7×	260 0.6×	135 0.4×	32 0.1×	30	2.6k
Volker Rickerts Germany	24	1.7k 0.6×	1.3k 0.5×	269 0.6×	80 0.2×	60 0.2×	85	2.1k

Countries citing papers authored by Maureen Roden

Since Specialization

Citations

This map shows the geographic impact of Maureen Roden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maureen Roden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maureen Roden more than expected).

Fields of papers citing papers by Maureen Roden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maureen Roden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maureen Roden. The network helps show where Maureen Roden may publish in the future.

Co-authorship network of co-authors of Maureen Roden

This figure shows the co-authorship network connecting the top 25 collaborators of Maureen Roden. A scholar is included among the top collaborators of Maureen Roden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maureen Roden. Maureen Roden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

1.

Schloot, Nanette C., Maureen Roden, Stefan R. Bornstein, & Matthias Brendel. (2011). Neue Therapieansätze beim Diabetes mellitus Typ 1. DMW - Deutsche Medizinische Wochenschrift. 136(5). 172–175. 3 indexed citations

2.

Menge, Til, Nanette C. Schloot, M. Schott, et al.. (2009). INTERFERON BETA TREATMENT DOES NOT INDUCE ORGAN-SPECIFIC AUTOANTIBODIES IN MULTIPLE SCLEROSIS. Neurology. 73(11). 900–902. 1 indexed citations

3.

Stergiopoulou, Theodouli, Joseph Meletiadis, Emmanuel Roilides, et al.. (2007). Host-Dependent Patterns of Tissue Injury in Invasive Pulmonary Aspergillosis. American Journal of Clinical Pathology. 127(3). 349–355. 105 indexed citations

4.

Stergiopoulou, Theodouli, Joseph Meletiadis, Emmanuel Roilides, et al.. (2007). Host-Dependent Patterns of Tissue Injury in Invasive Pulmonary Aspergillosis. American Journal of Clinical Pathology. 127(3). 349–355. 2 indexed citations

5.

Benjamin, Daniel K., Timothy Driscoll, Nita L. Seibel, et al.. (2006). Safety and Pharmacokinetics of Intravenous Anidulafungin in Children with Neutropenia at High Risk for Invasive Fungal Infections. Antimicrobial Agents and Chemotherapy. 50(2). 632–638. 152 indexed citations

6.

Roden, Maureen, Theoklis E. Zaoutis, Wendy Buchanan, et al.. (2005). Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases. Clinical Infectious Diseases. 41(5). 634–653. 2071 indexed citations breakdown →

7.

Walsh, Thomas J., Peter C. Adamson, Nita L. Seibel, et al.. (2005). Pharmacokinetics, Safety, and Tolerability of Caspofungin in Children and Adolescents. Antimicrobial Agents and Chemotherapy. 49(11). 4536–4545. 165 indexed citations

8.

Roden, Maureen, Paul Jarosinski, Judith Starling, et al.. (2003). Triad of Acute Infusion‐Related Reactions Associated with Liposomal Amphotericin B: Analysis of Clinical and Epidemiological Characteristics. Clinical Infectious Diseases. 36(10). 1213–1220. 71 indexed citations

9.

Walsh, Thomas J., Irja Lutsar, Timothy Driscoll, et al.. (2002). Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children. The Pediatric Infectious Disease Journal. 21(3). 240–248. 317 indexed citations

10.

Groll, Andreas H., Lauren V. Wood, Maureen Roden, et al.. (2002). Safety, Pharmacokinetics, and Pharmacodynamics of Cyclodextrin Itraconazole in Pediatric Patients with Oropharyngeal Candidiasis. Antimicrobial Agents and Chemotherapy. 46(8). 2554–2563. 77 indexed citations

11.

Walsh, Thomas J., Jesse L. Goodman, Peter G. Pappas, et al.. (2001). Safety, Tolerance, and Pharmacokinetics of High-Dose Liposomal Amphotericin B (AmBisome) in Patients Infected withAspergillusSpecies and Other Filamentous Fungi: Maximum Tolerated Dose Study. Antimicrobial Agents and Chemotherapy. 45(12). 3487–3496. 278 indexed citations

12.

Walsh, Thomas J., Maureen Roden, Emmanuel Roilides, & Andreas H. Groll. (2000). Concepts in design of comparative clinical trials of antifungal therapy in neutropenic patients. International Journal of Antimicrobial Agents. 16(2). 151–156. 2 indexed citations

13.

Müller, Frank‐Michael C., Miki Kasai, Andrea Francesconi, et al.. (1999). Transmission of an Azole-Resistant Isogenic Strain of Candida albicans among Human Immunodeficiency Virus-Infected Family Members with Oropharyngeal Candidiasis. Journal of Clinical Microbiology. 37(10). 3405–3408. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact